BioSpace News Archive

Policy

Oklahoma Pegs J&J with $527 Million Opioid Verdict

Between J&J, Purdue ($270 million), and Israel-based Teva Pharmaceuticals ($85 million), Oklahoma will garner about $927 million – a far cry from the $20 billion the state had been seeking in damages related to the opioid crisis.

August 27, 2019

·

3 min read

·

Alex Keown

BioCapital

Alliance for Regenerative Medicine Issues Guiding Ethical Principles for Gene Editing

The Alliance for Regenerative Medicine, which calls itself an “international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector,” issued a bioethical framework for gene editing’s use in therapeutic applications.

August 27, 2019

·

3 min read

·

Mark Terry

Policy

After Rejection, FDA Grants Fast Track Designation to Diabetes Drug Farxiga

AstraZeneca said the FDA awarded the designation to Farxiga to delay the progression of renal failure and prevent cardiovascular and renal death in patients with chronic kidney disease.

August 27, 2019

·

2 min read

·

Alex Keown

Career Advice

How to Nail Your First Biopharma Interview After College

The first biopharma interview after college will increase your stress and anxiety. However, we offer a few time-tested tips to help you nail your first interview.

August 27, 2019

·

4 min read

·

Don Potochny

Pharm Country

Seeking Small Molecule Drugs to Control mRNA Translation

Wouldn’t it be amazing to be able to see a protein being made in a cell in real time? And wouldn’t it be even better if you could use that capability to discover new drugs to previously “undruggable” targets, creating new medicines? Well that’s exactly what Anima Biotech is aiming to do.

August 27, 2019

·

13 min read

·

Chelsea Weidman Burke

Bio NC

Nanospectra’s Nanoparticle Light Therapy for Prostate Cancer Shows Promise

AuroLase Therapy is a focal ablation treatment utilizing gold nanoparticles. The nanoparticles heat and destroy cancer cells.

August 27, 2019

·

3 min read

·

Mark Terry

Policy

The Alliance for Regenerative Medicine Releases Statement of Principles on Genome Editing

The Alliance for Regenerative Medicine released a Therapeutic Developers’ Statement of Principles, setting forth a bioethical framework for the use of gene editing in therapeutic applications.

August 27, 2019

·

5 min read

Policy

Rentschler Fill Solutions receives open-ended GMP certification by the Austrian authority AGES

Pharmaceutical manufacturing license and GMP compliance of the Rentschler Fill Solutions plant reconfirmed by the Austrian Agency for Health and Food Safety (AGES)

August 27, 2019

·

2 min read

Business

Velabs Therapeutics Enters into a Screening Cooperation with Chiome Bioscience in the Field of GPCR-Specific Functional Antibody Screening After Successful Feasibility Study

Velabs Therapeutics announced that its cooperation with Chiome Bioscience, Inc., Tokyo, will be deepened, to jointly discover modulatory and functional antibodies for one of Chiome’s GPCR target genes.

August 27, 2019

·

3 min read

Pharm Country

Alfa Chemistry Offers Metal Nanomaterial Products

On August 25, 2019, Alfa Chemistry announced that they can offer various metal nanomaterial products to meet the different needs of their customers.

August 27, 2019

·

6 min read